Celcuity Inc logo

Celcuity Inc

CELC
Healthcare|Biotechnology|USA
$107.58
-5.93 (-5.22%)
Tangible Book
$1.11
Earnings Power
$1.12

Analyst Estimates

annual
{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 42.08, 408.28, 763.2, 1196.22, 1668.84 ], "ebit_estimate": [ -211.6, -12.91, 229.77, 533.95, 853.86 ], "ebitda_estimate": [ -238.4, -97.4, null, null, null ], "net_income_estimate": [ -217.33, -15.59, 215.34, 499.88, 763.07 ], "per_share_eps_estimate": [ -4.02, -0.77, 3.43, 7.68, 11.65 ], "eps_nri_estimate": [ -4.02, -0.75, 3.39, 7.68, 11.65 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null ], "pretax_income_estimate": [ -216, -35.16, 201.74, 510.59, 892.24 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null ], "gross_margin_estimate": [ 75.25, 79.65, 84.37, 86.17, 88 ], "operating_cash_flow_estimate": [ null, null, null, null, null ], "pettm_estimate": [ 0, 0, 31.4, 14, 9.23 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }
quarterly
{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712", "202803" ], "revenue_estimate": [ null, 9.81, 32.28, 47.52, 65.23, 91.95, 117.42, null ], "ebit_estimate": [ -58.16, -58.18, -44.36, -35.88, -22.53, 11.3, 36, null ], "ebitda_estimate": [ -63, -65.9, -59, -49.7, -35.6, -15.1, 3, null ], "net_income_estimate": [ -59.29, -59.7, -45.59, -37.9, -23.73, 9.32, 34.8, null ], "per_share_eps_estimate": [ -1.11, -1.1, -0.83, -0.23, -0.6, -0.44, 0.11, null ], "eps_nri_estimate": [ -1.11, -1.1, -0.83, -0.23, -0.6, -0.24, 0.11, -0.55 ], "dividend_estimate": [ null, null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null, null ], "pretax_income_estimate": [ -58.57, -59.28, -45.41, -37.9, -23.73, 9.32, -37.34, null ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null, null ], "gross_margin_estimate": [ null, 74.25, 75.5, 80, 81, 83, 83, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }